Intrathecal Baclofen therapy for severe spasticity in MS
Intrathecal Baclofen therapy for severe spasticity in MS
A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.
The paper, published this week as an OnlineFirst article inMultiple Sclerosis Journal, recommends physician evaluation of ITB therapy as a treatment option for patients at all clinical stages of MS who are intolerant of or unresponsive to oral spasticity therapies...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1913
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1063 Views
-
Last post by NHE
-
- 0 Replies
- 1994 Views
-
Last post by frodo
-
- 5 Replies
- 1202 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1085 Views
-
Last post by NHE
-
- 0 Replies
- 1627 Views
-
Last post by Petr75
-
- 0 Replies
- 8713 Views
-
Last post by NHE
-
- 2 Replies
- 1714 Views
-
Last post by frodo
-
- 0 Replies
- 2294 Views
-
Last post by NHE
-
- 0 Replies
- 2331 Views
-
Last post by frodo